StonvexLoading…
StonvexStonvexStonvexCore line items from GBCS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $41.44M | $39.49M | $36.78M | $40.60M |
Operating Income | $-1.56M | $-2.73M | $-8.96M | $-286.57K |
Net Income | $-1.02M | $-2.42M | $-3.97M | $-2.40M |
EPS (Diluted) | $-0.34 | $-0.80 | $-1.31 | $-0.79 |
Total Assets | $32.58M | $33.45M | $40.67M | $42.49M |
Total Liabilities | $38.79M | $38.86M | $43.64M | $41.54M |
Cash & Equivalents | $1.01M | $680.33K | $1.48M | $1.42M |
Free Cash Flow OCF − CapEx | $1.44M | $-1.86M | $506.86K | $-527.51K |
Shares Outstanding | 3.07M | 3.07M | 3.07M | 3.07M |